Oliva-Damaso, N., & Bomback, A. S. (2021). Rituximab Is Preferable to Cyclophosphamide for Treatment of Membranous Nephropathy: PRO. Kidney360, 2(11), 1696–1698. https://doi.org/10.34067/kid.0001842021
Columbia Affiliation:
Subjects:
Publication Type:
Article
Unique ID:
10.34067/kid.0001842021
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: